Alan Fuhrman

Insider Reports History

Location
San Diego, CA
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Fuhrman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tyra Biosciences, Inc. Chief Financial Officer Common Stock 14,788 $134,999 $9.13 15 Sep 2025 Direct
Esperion Therapeutics, Inc. Director Common Stock 53,404 $132,602 $2.48 23 May 2024 Direct
SpringWorks Therapeutics, Inc. Director Common Stock 0 $0 $46.74 01 Jul 2025 Direct
Tyra Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 170,000 07 Aug 2025 Direct
Esperion Therapeutics, Inc. Director Stock Option (right to buy) 32,500 23 May 2024 Direct
Checkmate Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 31 May 2022 Direct
SpringWorks Therapeutics, Inc. Director Stock Option (Right to Buy) 0 01 Jul 2025 Direct

Insider Reports Filed by Alan Fuhrman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TYRA Tyra Biosciences, Inc. 15 Sep 2025 1 +$6,399 4 Chief Financial Officer 17 Sep 2025, 17:57
TYRA Tyra Biosciences, Inc. 07 Aug 2025 1 $0 4 Chief Financial Officer 07 Aug 2025, 16:43
SWTX SpringWorks Therapeutics, Inc. 01 Jul 2025 6 $0 4 Director 02 Jul 2025, 16:24
SWTX SpringWorks Therapeutics, Inc. 14 May 2025 1 $0 4 Director 15 May 2025, 18:43
TYRA Tyra Biosciences, Inc. 14 Mar 2025 1 +$12,101 4 Chief Financial Officer 18 Mar 2025, 18:44
TYRA Tyra Biosciences, Inc. 30 Oct 2024 1 +$151,954 4 Chief Financial Officer 01 Nov 2024, 16:22
TYRA Tyra Biosciences, Inc. 13 Sep 2024 1 +$11,904 4 Chief Financial Officer 17 Sep 2024, 17:12
TYRA Tyra Biosciences, Inc. 14 Aug 2024 1 $0 4 Chief Financial Officer 16 Aug 2024, 17:18
ESPR Esperion Therapeutics, Inc. 23 May 2024 2 $0 4 Director 24 May 2024, 16:17
SWTX SpringWorks Therapeutics, Inc. 16 May 2024 2 $0 4 Director 17 May 2024, 16:03
TYRA Tyra Biosciences, Inc. 15 Mar 2024 1 +$11,629 4 Chief Financial Officer 19 Mar 2024, 20:01
TYRA Tyra Biosciences, Inc. 15 Sep 2023 1 +$18,293 4 Chief Financial Officer 19 Sep 2023, 19:27
TYRA Tyra Biosciences, Inc. 28 Jul 2023 1 $0 4 Chief Financial Officer 01 Aug 2023, 17:34
ESPR Esperion Therapeutics, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:09
SWTX SpringWorks Therapeutics, Inc. 24 May 2023 2 $0 4 Director 25 May 2023, 16:25
TYRA Tyra Biosciences, Inc. 01 Jan 2023 2 $0 4 Chief Financial Officer 03 Jan 2023, 16:01
TYRA Tyra Biosciences, Inc. 01 Jan 2023 0 $0 3 Chief Financial Officer 03 Jan 2023, 15:58
/report/000089924322020078-fuhrman-alan-2022-05-31 Checkmate Pharmaceuticals, Inc. 31 May 2022 3 $0 4 Director 31 May 2022, 10:02
ESPR Esperion Therapeutics, Inc. 26 May 2022 1 $0 4 Director 27 May 2022, 16:12
SWTX SpringWorks Therapeutics, Inc. 19 May 2022 2 $0 4 Director 20 May 2022, 17:41
/report/000089924321042072-fuhrman-alan-2021-10-27 Checkmate Pharmaceuticals, Inc. 27 Oct 2021 1 $0 4 Interim President and Chief Executive Officer, Director 29 Oct 2021, 18:54
/report/000089924321025178-fuhrman-alan-2021-06-16 Checkmate Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 21:22
ESPR Esperion Therapeutics, Inc. 27 May 2021 1 $0 4 Director 28 May 2021, 16:19
SWTX SpringWorks Therapeutics, Inc. 20 May 2021 2 $0 4 Director 21 May 2021, 16:32